國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Hodgkin lymphomaa comprehensive over...

Engert, Andreas.

Hodgkin lymphomaa comprehensive overview /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Hodgkin lymphomaedited by Andreas Engert, Anas Younes.
其他題名:	a comprehensive overview /
其他作者:	Engert, Andreas.
出版者:	Cham :Springer International Publishing :2020.
面頁冊數:	ix, 509 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Hodgkin's disease.
電子資源:	https://doi.org/10.1007/978-3-030-32482-7
ISBN:	9783030324827$q(electronic bk.)

Hodgkin lymphomaa comprehensive overview /
Hodgkin lymphomaa comprehensive overview /[electronic resource] :edited by Andreas Engert, Anas Younes. - Third edition. - Cham :Springer International Publishing :2020. - ix, 509 p. :ill., digital ;24 cm. - Hematologic malignancies,2197-9766. - Hematologic malignancies..

Part I: Epidemiology and Pathogenesis -- Epidemiology of Hodgkin Lymphoma -- The role of viruses in the genesis of Hodgkin Lymphoma -- Pathology and molecular pathology of Hodgkin Lymphoma -- Microenvironment, cross-talk and immune escape mechanisms -- What will we learn from Genomics and Proteomics in Hodgkin Lymphoma? -- Part II: Diagnosis and first-line treatment -- Clinical evaluation -- Functional imaging in Hodgkin Lymphoma -- Prognostic factors. - Principles of Radiation Therapy for Hodgkin Lymphoma -- Principles of chemotherapy in Hodgkin Lymphoma -- Treatment of early favorable Hodgkin Lymphoma -- Treatment of early unfavorable Hodgkin Lymphoma -- Treatment of advanced-stage Hodgkin Lymphoma -- Optimizing Decision Making in HL -- Part III: Special clinical situations -- Paediatric/adolescent Hodgkin Lymphoma -- The management of elderly patients with Hodgkin Lymphoma -- Nodular Lymphocyte-Predominant Hodgkin Lymphoma -- The management of Hodgkin Lymphoma during pregnancy -- The management of HIV-Hodgkin Lymphoma -- Part IV: Relapsed and refractory disease -- Relapsed and refractory Hodgkin Lymphoma -- Allogeneic transplantation for relapsed Hodgkin Lymphoma -- Targeting CD30 in Patients with Hodgkin Lymphoma -- Hodgkin Lymphoma and PD-1 blockade -- Other new agents for Hodgkin Lymphoma -- Part V: Survivorship -- Quality of Life in Hodgkin lymphoma -- Second malignancy risk after treatment of Hodgkin Lymphoma -- Cardiovascular and pulmonary late effects -- Gonadal dysfunction and fertility preservation in Hodgkin Lymphoma patients -- Fatigue.

This book, now in its third edition, examines the current treatment options for first-line, relapsed, and refractory Hodgkin lymphoma and the appropriate management in special clinical circumstances, including in the elderly, pregnant women, and those with nodular lymphocyte-predominant disease (NLPHL) Careful attention is devoted to the emerging individually tailored treatment strategies, including checkpoint inhibition, that are especially appealing given their potential to reduce early and late treatment side effects in this generally young patient population. In addition, clear guidance is provided on the management of Hodgkin survivors. Other topics addressed include epidemiology, pathogenesis, the role of the microenvironment, initial clinical evaluation, imaging diagnosis, use of staging systems, and prognostic factors. The new edition of Hodgkin Lymphoma: A Comprehensive Overview has been revised and updated by key opinion leaders to reflect recent progress in the field. It will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma.

ISBN: 9783030324827$q(electronic bk.)

Standard No.: 10.1007/978-3-030-32482-7doiSubjects--Topical Terms:

281411
Hodgkin's disease.

LC Class. No.: RC644 / .H634 2020

Dewey Class. No.: 616.9944606

Hodgkin lymphomaa comprehensive overview /
LDR:03727nmm a2200349 a 4500 001 572899
003 DE-He213
005 20200806160158.0
006 m d
007 cr nn 008maaau
008 200925s2020 sz s 0 eng d
020 $a 9783030324827$q(electronic bk.)
020 $a 9783030324810$q(paper)
024 7 $a 10.1007/978-3-030-32482-7 $2 doi
035 $a 978-3-030-32482-7
040 $a GP $c GP
041 0 $a eng
050 4 $a RC644 $b .H634 2020
072 7 $a MJF $2 bicssc
072 7 $a MED038000 $2 bisacsh
072 7 $a MJF $2 thema
082 0 4 $a 616.9944606 $2 23
090 $a RC644 $b .H689 2020
245 0 0 $a Hodgkin lymphoma $h [electronic resource] : $b a comprehensive overview / $c edited by Andreas Engert, Anas Younes.
250 $a Third edition.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a ix, 509 p. : $b ill., digital ; $c 24 cm.
490 1 $a Hematologic malignancies, $x 2197-9766
505 0 $a Part I: Epidemiology and Pathogenesis -- Epidemiology of Hodgkin Lymphoma -- The role of viruses in the genesis of Hodgkin Lymphoma -- Pathology and molecular pathology of Hodgkin Lymphoma -- Microenvironment, cross-talk and immune escape mechanisms -- What will we learn from Genomics and Proteomics in Hodgkin Lymphoma? -- Part II: Diagnosis and first-line treatment -- Clinical evaluation -- Functional imaging in Hodgkin Lymphoma -- Prognostic factors. - Principles of Radiation Therapy for Hodgkin Lymphoma -- Principles of chemotherapy in Hodgkin Lymphoma -- Treatment of early favorable Hodgkin Lymphoma -- Treatment of early unfavorable Hodgkin Lymphoma -- Treatment of advanced-stage Hodgkin Lymphoma -- Optimizing Decision Making in HL -- Part III: Special clinical situations -- Paediatric/adolescent Hodgkin Lymphoma -- The management of elderly patients with Hodgkin Lymphoma -- Nodular Lymphocyte-Predominant Hodgkin Lymphoma -- The management of Hodgkin Lymphoma during pregnancy -- The management of HIV-Hodgkin Lymphoma -- Part IV: Relapsed and refractory disease -- Relapsed and refractory Hodgkin Lymphoma -- Allogeneic transplantation for relapsed Hodgkin Lymphoma -- Targeting CD30 in Patients with Hodgkin Lymphoma -- Hodgkin Lymphoma and PD-1 blockade -- Other new agents for Hodgkin Lymphoma -- Part V: Survivorship -- Quality of Life in Hodgkin lymphoma -- Second malignancy risk after treatment of Hodgkin Lymphoma -- Cardiovascular and pulmonary late effects -- Gonadal dysfunction and fertility preservation in Hodgkin Lymphoma patients -- Fatigue.
520 $a This book, now in its third edition, examines the current treatment options for first-line, relapsed, and refractory Hodgkin lymphoma and the appropriate management in special clinical circumstances, including in the elderly, pregnant women, and those with nodular lymphocyte-predominant disease (NLPHL) Careful attention is devoted to the emerging individually tailored treatment strategies, including checkpoint inhibition, that are especially appealing given their potential to reduce early and late treatment side effects in this generally young patient population. In addition, clear guidance is provided on the management of Hodgkin survivors. Other topics addressed include epidemiology, pathogenesis, the role of the microenvironment, initial clinical evaluation, imaging diagnosis, use of staging systems, and prognostic factors. The new edition of Hodgkin Lymphoma: A Comprehensive Overview has been revised and updated by key opinion leaders to reflect recent progress in the field. It will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma.
650 0 $a Hodgkin's disease. $3 281411
650 1 4 $a Hematology. $3 274899
650 2 4 $a Oncology. $3 195181
700 1 $a Engert, Andreas. $3 509086
700 1 $a Younes, Anas. $3 713813
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Hematologic malignancies. $3 560151
856 4 0 $u https://doi.org/10.1007/978-3-030-32482-7
950 $a Medicine (Springer-11650)